Exposure to certain uridinediphospho-glucuronyl transferase (UDPGT) inducers can lead to follicular cell hypcrplasia and ultimately thyroid gland tumors. These compounds often decrease thyroid hormone levels, which increases serum concentrations of thyroidstimulating hormone (TSH). This induction of TSH increases thyroidfollicular cell proliferation. In addition, treatment with classical goitrogenic compounds induces both T-cell growth factor (TGF) PI messenger RNA and protein in thyroid-follicular cells, presumably through increased TSH. In other tissues, increases in TGF-(3, induce a particular form of programmed cell death. apoptosis. In this experiment, we sought to determine whether the UDPGT inducers phenobarbital (PB) and pregnenolone-l6cc-~arbonitril (PCN) modulate thyroid follicular cell apoptosis. If so, is there an association between apoptosis induction Cnd immunohistochemical detection of TGF-PI? An additional group treated with propylthiouracil (PTU), which has been previously shown to increase the expression and production of TGF-PIin thyroid-follicular cells, was included. In this study, apoptosis was increased in PTU-treated rats in a manner that appeared to be associated with increased levels of TGF-P,. PTU treatment of rats produced the largest number of TGF-P,-positive cells and led to the largest percentage of apoptotic thyroid-follicular cells. In PB-and PCN-treated rats, a moderate increase in apoptosis coincided with similar increases in cells that were TGF-PI immunoreactive. The increased percentage of TGF-P,-positive follicular cells and presumptive production of TGF-PI may help regulate thyroid growth induced by the UDPGT inducing agents PB and PCN, possibly by modulating apoptosis in susceptible thyroid-follicular cells. Histochemical analysis shows an accumulation of neutral lipid (found using Oil Red 0 and Nile Red dyes) in the capillaries and epithelial cells of the renal medulla in humans with analgesic nephropathy. This finding is also present in a number of other species (rat. mouse, pig, and nonhuman primate) exposed to several model papillotoxic agents. These changes are pathognomonic for renal papillary necrosis, but detailed chemical analyses of the kidney and urine has never been reported. In order to chemically characterize this lipid aberration. we have analyzed urine and renal tissue from rodents given 2-bromoethylamine (BEA) and N-phenylanthranilic acid (NPAA), which induced renal papillary necrosis (RPN) acutely and subacutely. Each chemical was administercd at 3 dose levels to groups of 5 male rats.
NGUYEN THI KIM THANH,' BERNHARD A1CHER,2 MANFRED
BEA was given as single intraperitoneal doses of 30, 90, and 240 mg per kilogram of body weight, while NPAA was given orally at doses of 100. 250, and 500 mg/kg daily for 11 days. Urine was collected at 0-4°C for 16 hr on days 1-4 in the case of BEA and on days 1-4 and 8-1 1 for NPAA. The kidney was removed at the end of the experiment and homogenized. Both the homogenate and urine were extracted with methanol :chloroform 2: 1 (v/v). and aliquots were separated on silica gel plates using high-performance thin laycr chromatography and assessed for lipid changes by in siru scanning densitometry.
In BEA-treated animals, there was a significant increase 01 < 0.05) in total phospholipids in urine after the first day but not on days 2-4.
This effect was seen at all dosages of BEA. In kidney tissue, there was a significant decrease in phospholipid and cholesterol following administration of 9 0 and 240 mgkg. respectively. However, a significant increase in triacetylglycerols was seen at the highest dose level.
NPAA caused a significant incrcase in total phospholipids on days 1. 10. and 1 1 following doses of 500 mgkg. There was a significant increase of phospholipid at 100 and 250 m@g on days 9, 10, and 11.
There was evidence that the urinary excretion of phosphatidylcholine and sphingomyelin significantly increased, but only following 250 and 500 mgkg doses. In the kidney tissue, there was an increase in cardiolipin following 250 and 500 m g k g doses. ' These data show that the histochemical changes reported in experimentally induced RPN represent aberrations in tissue phospholipids, show that these can be chemically quantifiable. and suggest that lipid determination may be a useful marker of renal papillary necrosis.
These investigations were supported by HEFCE. was assessed. Slices were incubated at 37°C for 4 hr with PAR or PAP and caffeine in oxygenated culture medium. The cellular viability of the slices was assessed by measurement of mitochondrial reduction of tetrazolium salt (MTT). In addition, thiobarbituric acid reactive substances (TBARS), reduced gluthathione (GSH), and leakage of lactate dehydrogenase (LDH) into the culture medium were measured.
The addition of caffeine alone caused a marked reduction of mitochondrial dehydrogenase activity that was significant at concentrations 25.0 mi and had an additive effect on the toxicity of PAP at concentrations of 20.5 rn\i. However, at concentrations of caffeine 2 2 0 nat and PAP 20.5 m\I. there was a significant decrease in mitochondria1 activity. which was not observed with caffeine 25.0 nar and PAR at any concentration studied. There were significant changes in GSH as a result of PAP in that concentrations 20.2 m\i caused a loss of GSH, which was not affected by caffeine. PAR, however, did not cause a significant depletion of GSH. No significant changes in levels of LDH leakage were observed in control rats, confirming that the mechanism of toxicity is not through membrane damage. The addition of PAP significantly increased the levels of TBARS in kidney slices at concentrations 20.5 m.1, but caffeine did not have a significant effect.
Thus. low concentrations of caffeine have a profound effect on the mitochondria1 activity within renal cortical slices, but at these concentrations does not affect nephrotoxicity of PAR or PAP in virro.
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